EQT bid deadline for Dechra Pharmaceuticals pushed back
Dechra Pharmaceuticals
3,866.00p
08:01 16/01/24
0.00%
0.00p
Dechra Pharmaceuticals said on Thursday that a deadline for Swedish private firm EQT to either announce a firm intention to make an offer for the company or walk away has been extended.
FTSE 250
20,356.07
14:45 18/11/24
n/a
n/a
FTSE 350
4,462.29
14:45 18/11/24
n/a
n/a
FTSE All-Share
4,420.03
14:45 18/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
19,157.67
14:45 18/11/24
-0.52%
-100.05
The veterinary pharmaceuticals group announced in April that it had entered into talks with EQT about a possible £4.6bn takeover bid. The ‘put up or shut up’ deadline for EQT was originally Tuesday 11 May, but this has been pushed back to 2 June.
"With the support of Dechra's management and board, EQT has made substantial progress towards completing its confirmatory due diligence and preparing the documentation necessary to implement a firm offer," Dechra said.